PTCHF
Price
$1.75
Change
+$0.07 (+4.17%)
Updated
Jun 17 closing price
Capitalization
416.65M
RVXCF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
8.33M
Interact to see
Advertisement

PTCHF vs RVXCF

Header iconPTCHF vs RVXCF Comparison
Open Charts PTCHF vs RVXCFBanner chart's image
PureTech Health
Price$1.75
Change+$0.07 (+4.17%)
Volume$10K
Capitalization416.65M
Resverlogix
Price$0.03
Change-$0.00 (-0.00%)
Volume$100K
Capitalization8.33M
PTCHF vs RVXCF Comparison Chart in %
Loading...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTCHF vs. RVXCF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTCHF is a Hold and RVXCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (PTCHF: $1.75 vs. RVXCF: $0.03)
Brand notoriety: PTCHF and RVXCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTCHF: 423% vs. RVXCF: 1026%
Market capitalization -- PTCHF: $416.65M vs. RVXCF: $8.33M
PTCHF [@Biotechnology] is valued at $416.65M. RVXCF’s [@Biotechnology] market capitalization is $8.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTCHF’s FA Score shows that 0 FA rating(s) are green whileRVXCF’s FA Score has 1 green FA rating(s).

  • PTCHF’s FA Score: 0 green, 5 red.
  • RVXCF’s FA Score: 1 green, 4 red.
According to our system of comparison, PTCHF is a better buy in the long-term than RVXCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTCHF’s TA Score shows that 2 TA indicator(s) are bullish while RVXCF’s TA Score has 5 bullish TA indicator(s).

  • PTCHF’s TA Score: 2 bullish, 2 bearish.
  • RVXCF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RVXCF is a better buy in the short-term than PTCHF.

Price Growth

PTCHF (@Biotechnology) experienced а 0.00% price change this week, while RVXCF (@Biotechnology) price change was +17.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($417M) has a higher market cap than RVXCF($8.33M). PTCHF YTD gains are higher at: -12.500 vs. RVXCF (-20.639).
PTCHFRVXCFPTCHF / RVXCF
Capitalization417M8.33M5,004%
EBITDAN/A-10.54M-
Gain YTD-12.500-20.63961%
P/E Ratio8.33N/A-
RevenueN/A0-
Total CashN/A153K-
Total DebtN/A17.6M-
FUNDAMENTALS RATINGS
PTCHF vs RVXCF: Fundamental Ratings
PTCHF
RVXCF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
6180
P/E GROWTH RATING
1..100
4695
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVXCF's Valuation (30) in the null industry is in the same range as PTCHF (54). This means that RVXCF’s stock grew similarly to PTCHF’s over the last 12 months.

RVXCF's Profit vs Risk Rating (100) in the null industry is in the same range as PTCHF (100). This means that RVXCF’s stock grew similarly to PTCHF’s over the last 12 months.

PTCHF's SMR Rating (91) in the null industry is in the same range as RVXCF (100). This means that PTCHF’s stock grew similarly to RVXCF’s over the last 12 months.

PTCHF's Price Growth Rating (61) in the null industry is in the same range as RVXCF (80). This means that PTCHF’s stock grew similarly to RVXCF’s over the last 12 months.

PTCHF's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for RVXCF (95). This means that PTCHF’s stock grew somewhat faster than RVXCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTCHFRVXCF
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
68%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEQIX36.980.20
+0.54%
Johnson Equity Income
JIREX11.980.05
+0.42%
JHancock Real Estate Securities 1
TSEMX16.390.05
+0.31%
Touchstone Sands Cptl Emerg Mkts Gr Y
VUIAX88.230.21
+0.24%
Vanguard Utilities Index Adm
LSHCX27.54-0.40
-1.43%
Kinetics Spin-Off and Corp Rest Adv C

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and PHGE have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
PHGE - PTCHF
22%
Poorly correlated
-2.22%
BCTX - PTCHF
22%
Poorly correlated
-4.82%
ACET - PTCHF
20%
Poorly correlated
-6.71%
SBMFF - PTCHF
18%
Poorly correlated
N/A
RVXCF - PTCHF
10%
Poorly correlated
-0.33%
More

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and FULC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and FULC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
-0.33%
FULC - RVXCF
25%
Poorly correlated
-3.79%
TELIF - RVXCF
23%
Poorly correlated
-24.40%
ATNM - RVXCF
22%
Poorly correlated
-12.35%
NGNE - RVXCF
21%
Poorly correlated
-2.47%
IDYA - RVXCF
20%
Poorly correlated
-4.13%
More